
What We’re Reading: Additional COVID-19 Booster; Postpartum Depression Rates During Pandemic; Children’s Mental Health
Pfizer and BioNTech requested FDA emergency use authorization for a fourth COVID-19 dose for older adults; postpartum depression rates tripled during early months of the COVID-19 pandemic; anxiety and depression diagnoses among children each increased by roughly 25% since 2016.
Pfizer Seeks EUA of Fourth COVID-19 Dose for Older Adults
Pfizer and BioNTech requested FDA emergency use authorization (EUA) for a second COVID-19 booster dose, or fourth vaccine dose, for adults 65 years and older,
Postpartum Depression Rates Tripled Early in COVID-19 Pandemic
According to
Children’s Mental Health Worsens Since 2016
The COVID-19 pandemic largely impacted children’s mental health, with anxiety and depression diagnoses significantly increasing (by 27% and 24%, respectively) between 2016 and 2020, specifically between 2019 and 2020.
Related to this article








